Functionalized polymeric patch for localized oxaliplatin delivery to treat gastric cancer

被引:23
作者
Bandi, Sony Priyanka [1 ]
Venuganti, Venkata Vamsi Krishna [1 ]
机构
[1] Birla Inst Technol & Sci BITS Pilani, Dept Pharm, Hyderabad Campus, Hyderabad 500078, Telangana, India
来源
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS | 2021年 / 128卷
关键词
Polymeric patch; Oxaliplatin; Gastric cancer; Mucoadhesion; AGS cells; ORAL DELIVERY; SYSTEMS; STABILITY; PLATFORM; FILMS;
D O I
10.1016/j.msec.2021.112302
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
Localized delivery of chemotherapeutic agents allows extended drug exposure at the target site, thereby reducing systemic toxicity. We report the development of functionalized polymeric patch with unidirectional drug release to treat gastric cancer. The oxaliplatin-loaded patch was prepared by incorporating sodium carboxymethyl cellulose, hydroxypropyl cellulose and polyvinylpyrrolidone. The patch was functionalized by coating with transferrin-poly(lactic-co-glycolic acid) conjugate on one side of the patch for cancer targeting. The other side of the patch was coated with ethylcellulose (EC) to restrict the release of oxaliplatin. The physical and mechanical properties of oxaliplatin-loaded patches were characterized. Mucoadhesion studies using excised rat stomach tissue have shown that the functionalized side of the patch has significantly (p < 0.05) greater mucoadhesion strength compared with EC coated side of the patch. The in vitro and ex vivo (stomach sac and open-membrane model) studies revealed greater permeation of oxaliplatin across the stomach tissue when adhered to the functionalized and non-functionalized side of the patch compared with EC coated side. It was found that the growth inhibition with oxaliplatin solution was not significantly greater compared with corresponding concentrations of oxaliplatin-loaded patch in AGS and Caco-2 cell models. The in vivo studies were performed in mice, where indocyanine green-loaded patch encapsulated in a gelatin capsule was orally administered. The near-infrared (NIR) optical imaging revealed adherence of the patch on the mucosal side of the stomach tissue for up to 6 h. In conclusion, the functionalized polymeric patch loaded with oxaliplatin can be a potential localized delivery system to target gastric cancer.
引用
收藏
页数:12
相关论文
共 29 条
[1]   Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells [J].
Arango, D ;
Wilson, AJ ;
Shi, Q ;
Corner, GA ;
Arañes, MJ ;
Nicholas, C ;
Lesser, M ;
Mariadason, JM ;
Augenlicht, LH .
BRITISH JOURNAL OF CANCER, 2004, 91 (11) :1931-1946
[2]   Changing Trends in Stomach Cancer Throughout the World [J].
Balakrishnan M. ;
George R. ;
Sharma A. ;
Graham D.Y. .
Current Gastroenterology Reports, 2017, 19 (8)
[3]   Advanced materials for drug delivery across mucosal barriers [J].
Bandi, Sony Priyanka ;
Bhatnagar, Shubhmita ;
Venuganti, Venkata Vamsi Krishna .
ACTA BIOMATERIALIA, 2021, 119 :13-29
[4]   Intestinal patch systems for oral drug delivery [J].
Banerjee, Amrita ;
Mitragotri, Samir .
CURRENT OPINION IN PHARMACOLOGY, 2017, 36 :58-65
[5]   Intestinal mucoadhesive devices for oral delivery of insulin [J].
Banerjee, Amrita ;
Lee, JooHee ;
Mitragotri, Samir .
BIOENGINEERING & TRANSLATIONAL MEDICINE, 2016, 1 (03) :338-346
[6]   Raise standards for preclinical cancer research [J].
Begley, C. Glenn ;
Ellis, Lee M. .
NATURE, 2012, 483 (7391) :531-533
[7]   Oral films: Current status and future perspectives I - Galenical development and quality attributes [J].
Borges, Ana Filipa ;
Silva, Claudia ;
Coelho, Jorge F. J. ;
Simoes, Sergio .
JOURNAL OF CONTROLLED RELEASE, 2015, 206 :1-19
[8]   The nanocomposite scaffold of poly(lactide-co-glycolide) and hydroxyapatite surface-grafted with L-lactic acid oligomer for bone repair [J].
Cui, Yang ;
Liu, Yi ;
Cui, Yi ;
Jing, Xiabin ;
Zhang, Peibiao ;
Chen, Xuesi .
ACTA BIOMATERIALIA, 2009, 5 (07) :2680-2692
[9]  
Cycle M.-C., 2019, POLYMERS-BASEL, V11, P1
[10]  
Das M, 2011, NANOMEDICINE-UK, V6, P489, DOI [10.2217/NNM.10.102, 10.2217/nnm.10.102]